Caspases is an important component in the neurobiology of neurodegenerative . This page provides detailed information about its structure, function, and role in disease processes.
Caspases (cysteine-aspartic proteases) are a family of cysteine protease enzymes that play essential roles in apoptosis (programmed cell death), neuroinflammation, and cellular homeostasis. The name derives from their catalytic mechanism: they are cysteine proteases that cleave substrates after aspartic acid residues. In the nervous system, caspases are central mediators of neuronal death across virtually all neurodegenerative , including alzheimers, parkinsons, huntington-pathway, and als (Bhatt et al., 2023). [@damelio2010]
At least 14 caspases have been identified in mammals, classified into three functional groups: initiator caspases (caspase-2, -8, -9, -10), effector/executioner caspases (caspase-3, -6, -7), and inflammatory caspases (caspase-1, -4, -5, -11, -12). Beyond their classical role in apoptosis, caspases are now recognized as key regulators of inflammasome activation, pyroptosis, necroptosis, synaptic pruning, and even non-death functions such as synaptic plasticity and axon guidance (D'Amelio et al., 2010; Bhatt et al., 2023). [@graham2006]
¶ Classification and Structure
Initiator caspases are activated first in the apoptotic cascade and subsequently activate effector caspases through proteolytic cleavage: [@li2000]
| Caspase | Activation Complex | Key Features | [@bhatt2019]
|---------|-------------------|--------------| [@rohn2001]
| Caspase-2 | PIDDosome | Responds to DNA damage, metabolic stress; role in neuronal death | [@su2001]
| Caspase-8 | DISC (Death-Inducing Signaling Complex) | Activated by death receptors (Fas, TNF-R, TRAIL-R); extrinsic apoptosis pathway; involved in amyloid-beta metabolism | [@bhatt2007]
| Caspase-9 | Apoptosome | Activated by cytochrome c release from mitochondria; intrinsic apoptosis pathway; major pathway in neurodegeneration | [@bhatt2006]
| Caspase-10 | DISC | Similar to caspase-8; primarily expressed in immune cells | [@bhatt2006a]
Executioner caspases carry out the proteolytic destruction of cellular components during apoptosis: [@apoptosis]
| Caspase | Substrates | Neurological Significance | [@neuroinflammation]
|---------|-----------|--------------------------| [@nlrpinflammasome]
| Caspase-3 | >600 substrates including PARP, DFF45, lamin A, app, tau], huntingtin | Principal executioner in neuronal apoptosis; enriched at synapses; cleaves tau] and app to generate toxic fragments | [@alzheimers]
| Caspase-6 | Lamin A, huntingtin, tau], app | Activated early in AD and HD; generates neurotoxic tau] and huntingtin fragments | [@als]
| Caspase-7 | PARP, DFF45 | Redundant with caspase-3; less studied in neurodegeneration |
Inflammatory caspases mediate innate immune responses and inflammatory cell death (pyroptosis):
| Caspase |
Function |
Neurological Significance |
| Caspase-1 |
Cleaves pro-IL-1β and pro-IL-18 to active forms; activates gasdermin D for pyroptosis |
Activated by nlrp3-inflammasome inflammasome]; drives neuroinflammation in AD, PD, ALS |
| Caspase-4/5 |
Non-canonical inflammasome activation; respond to intracellular LPS |
Emerging roles in neuroinflammation |
| Caspase-11 (mouse) |
Equivalent to human caspase-4/5 |
Studied in mouse models of neurodegeneration |
| Caspase-12 |
ER stress-induced apoptosis |
Activated in endoplasmic-reticulum-stress; relevant to protein misfolding |
The intrinsic apoptotic pathway is the predominant cell death mechanism in neurodegenerative , triggered by intracellular stresses including oxidative-stress, DNA damage, excitotoxicity, protein aggregation, and trophic factor withdrawal (Yuan & Bhatt, 2023):
- Stress signals: amyloid-beta, mutant sod1-protein, alpha-synuclein, or mutant huntingtin trigger cellular stress
- Bcl-2 family imbalance: Pro-apoptotic (Bax, Bak, Bad) overwhelm anti-apoptotic (Bcl-2, Bcl-xL), leading to mitochondrial outer membrane permeabilization (MOMP)
- Cytochrome c release: Cytochrome c is released from mitochondria into the cytoplasm
- Apoptosome formation: Cytochrome c binds to Apaf-1 (apoptotic protease-activating factor-1) and recruits pro-caspase-9, forming the apoptosome
- Caspase-9 activation: Within the apoptosome, caspase-9 undergoes autoproteolytic activation
- Executioner caspase activation: Active caspase-9 cleaves and activates caspase-3 and caspase-7
- Cellular demolition: Caspase-3/7 cleave hundreds of substrates, causing DNA fragmentation, cytoskeletal collapse, membrane blebbing, and formation of apoptotic bodies
Activated by external death ligands binding to cell surface death receptors:
- Ligand binding: TNF-α, FasL, or TRAIL bind to their respective death receptors (TNF-R1, Fas/CD95, TRAIL-R1/R2) on the neuronal surface
- DISC assembly: The receptor recruits FADD (Fas-associated death domain protein) and pro-caspase-8
- Caspase-8 activation: Proximity-induced dimerization activates caspase-8
- Direct executioner activation: Caspase-8 directly cleaves and activates caspase-3
- Cross-talk with intrinsic pathway: In neurons (type II cells), caspase-8 also cleaves Bid to truncated Bid (tBid), which activates the mitochondrial pathway, amplifying the apoptotic signal
The inflammatory caspase pathway is increasingly recognized in neurodegeneration:
- nlrp3-inflammasome activation: Danger signals such as amyloid-beta aggregates, alpha-synuclein fibrils, and oxidative-stress activate the inflammasome in [microglia[..
- Gasdermin D cleavage: Caspase-1 cleaves gasdermin D, which forms pores in the plasma membrane
- Pyroptosis: Pore formation leads to cell swelling, membrane rupture, and release of pro-inflammatory cellular contents
At least seven caspases (caspase-1, -2, -3, -6, -8, -9, and -12) have been implicated in alzheimers pathogenesis (Bhatt et al., 2023):
- Caspase-3: Activated in AD neurons and found in granulovacuolar degeneration bodies; cleaves app to generate C31, a neurotoxic fragment; cleaves tau] at Asp421 to generate a truncated form that aggregates more readily and promotes neurofibrillary tangle formation
- Caspase-6: Activated early in AD, even in mild cognitive impairment; cleaves tau] at multiple sites; elevated caspase-6 activity in the hippocampus and [entorhinal cortex correlates with cognitive decline
- Caspase-1: Activated by nlrp3-inflammasome in microglia
- Caspase-3: Activated in dopaminergic neurons of the substantia-nigra in PD; mediates MPTP-induced dopaminergic neuron death in animal models
- Caspase-9: Mitochondrial pathway activation by alpha-synuclein aggregates and mitochondrial complex I inhibition
- Caspase-1: nlrp3-inflammasome inflammasome activation by α-synuclein fibrils in dopaminergic neurons; pyroptosis contributes to progressive neuronal loss
- Caspase-8: TNF-α-mediated death receptor signaling contributes to dopaminergic neuron loss
- Caspase-6: Cleavage of huntingtin protein at Asp586 by caspase-6 generates a toxic N-terminal fragment that is critical for HD pathogenesis. Mice expressing caspase-6-resistant huntingtin are protected from HD phenotype (Graham et al., 2006)
- Caspase-3: Also cleaves huntingtin, generating additional toxic fragments
- Caspase-1 and caspase-3: Sequentially activated in sod1-protein transgenic mouse models of als, with caspase-1 activation preceding caspase-3 and clinical symptom onset
- Caspase-9: Mitochondrial pathway activation by mutant SOD1 protein
Caspases have important non-death functions in neurons:
- Synaptic plasticity: Caspase-3 is required for long-term depression (LTD) at excitatory synapses; local caspase-3 activation at synapses mediates AMPA receptor internalization without causing cell death (D'Amelio et al., 2010)
- Developmental pruning: Caspases mediate activity-dependent axon pruning and synapse elimination during brain development
- Axon degeneration: Local caspase-6 activation drives Wallerian degeneration of damaged axons
- Neurogenesis: Caspase-3 regulates neural progenitor cell differentiation in the adult hippocampus
- Microglial activation: Caspases regulate microglialphenotype switching and inflammatory responses without triggering microglial death
Several strategies to inhibit caspases for neuroprotection have been explored:
- Pan-caspase inhibitors (z-VAD-fmk, emricasan: Broad-spectrum inhibitors that block all caspases; show neuroprotection in animal models but lack specificity for clinical use
- Caspase-1 inhibitors (VX-765/belnacasan): Selective caspase-1 inhibitor that reduces IL-1β production and pyroptosis; shown to reduce amyloid-beta deposition and improve cognition in AD mouse models
- Caspase-3 inhibitors: Selective inhibitors under development; must balance neuroprotection against disruption of normal synaptic functions
- Caspase-6 inhibitors: Targeting caspase-6 to prevent toxic tau] and huntingtin cleavage; preclinical development
- Bcl-2 family modulators: Enhancing anti-apoptotic Bcl-2/Bcl-xL to prevent caspase activation
- nlrp3-inflammasome inhibitors (MCC950): Block upstream inflammasome activation to prevent caspase-1 engagement
- Minocycline: Tetracycline antibiotic with caspase-1 and caspase-3 inhibitory properties; tested in ALS and PD clinical trials with mixed results
- IAP (Inhibitor of apoptosis Proteins) enhancers: XIAP and other IAPs directly inhibit caspases; potential therapeutic targets
The study of Caspases has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PubMed - Biomedical literature
- Alzheimer's Disease Neuroimaging Initiative - Research data
- Allen Brain Atlas - Brain gene expression data
- Allen Human Brain Atlas: Caspases expression search
- Allen Mouse Brain Atlas: Caspases search
- Allen Cell Type Atlas: Transcriptomic cell type reference
- BrainSpan Developmental Transcriptome: Caspases developmental expression
- alpha-synuclein
- [Huntingtin (HTT)[//huntingtin
- sod1-protein
- [Bhatt, H. R., et al. (2023, Caspases in [alzheimers: Mechanism of activation, role, and potential treatment. Molecular Neurobiology, 61, 1855–1875. DOI (2023)
- [D'Amelio, M., et al., (2010. [Neuronal caspase-3 signaling: Not only cell death. Cell Death & Differentiation, 17, 1104–1114. DOI (2010)
- [Graham, R. K., et al. (2006, Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant [huntingtin. Cell, 125(6), 1179–1191. DOI (2006)
- [Li, M., et al., (2000. [Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science, 288(5464), 335–339. DOI (2000)
- [Bhatt, D. K., et al., (2019. [Brainiac caspases: Beyond the wall of apoptosis. Frontiers in Cellular Neuroscience, 13, 500. DOI (2019)
- [Rohn, T. T., et al. (2001, Activation of caspase-8 in the [alzheimers brain. Neurobiology of Disease, 8(6), 1006–1016. DOI (2001)
- [Su, J. H., et al., (2001. [Activated caspase-3 expression in Alzheimer's and aged control brain: Correlation with Alzheimer pathology (2001))
- [Bhatt, D. K., et al., (2007. [Caspase-6 gene disruption reveals a requirement in aging-related neurophysiological deficits. Cell Death & Differentiation, 14(12), 2158–2161. DOI (2007)
- [Bhatt, D. K., et al., (2006. Caspase-3 and caspase-6 cleave tau] into segments truncated at the amino and carboxyl termini (2006)(https://doi.org/10.1523/JNEUROSCI.0952-06.2006))
- [Bhatt, D. K., et al., (2006. [Early caspase-6 activation in Alzheimer's Disease. Journal of Neuropathology & Experimental Neurology, 65(6), 553–562. DOI (2006)
- Unknown, - apoptosis — Programmed cell death pathway involving caspases (n.d.)
- Unknown, - neuroinflammation — Inflammatory caspases in CNS inflammation (n.d.)
- Unknown, - nlrp3-inflammasome — Activates caspase-1 for pyroptosis (n.d.)
- Unknown, - alzheimers — Disease with caspase-mediated tau] cleavage and cell death (n.d.)
- Unknown, - als — Disease with caspase-mediated motor neuron death (n.d.)